Fund Holdings — PFIZER INC

Total Portfolio Value:
$437.45M
Total Bought:
$923.8K
Total Sold:
$226.83M
Net Transaction:
-$225.90M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
BioNTech SEADS(BNTX)3,658,3611,658,361-2,000,000$389.51M$163.55M37.39%-$225.96M
ORIC Pharmaceuticals, Inc.(ORIC)5,376,3445,376,3440$54.57M$64.52M14.75%+$9.95M
Tourmaline Bio Inc1,272,2141,272,2140$20.34M$60.85M13.91%+$40.51M
Arvinas, Inc.(ARVN)3,457,8153,457,8150$25.45M$29.46M6.73%+$4.01M
Allogene Therapeutics Inc22,032,04022,032,0400$24.90M$27.32M6.25%+$2.42M
Celcuity Inc.(CELC)349,406349,4060$4.66M$17.26M3.95%+$12.60M
Pyxis Oncology, Inc.(PYXS)7,032,7707,032,7700$7.74M$15.61M3.57%+$7.88M
Wave Life Sciences, Inc.SHS(WVE)1,875,0001,875,0000$12.19M$13.72M3.14%+$1.54M
Zura Bio LimitedCL A(ZURA)2,970,0222,970,0220$3.12M$12.86M2.94%+$9.74M
Caribou Biosciences, Inc.(CRBU)4,690,4314,690,4310$5.91M$10.93M2.50%+$5.02M
Biohaven Ltd.(BHVN)505,645505,6450$7.13M$7.59M1.73%+$455.1K
Cardiff Oncology, Inc.(CRDF)2,411,5752,411,5750$7.60M$4.97M1.14%-$2.63M
Spero Therapeutics, Inc.(SPRO)2,362,3482,362,3480$6.85M$4.44M1.02%-$2.41M
Zentalis Pharmaceuticals, Inc.(ZNTL)953,834953,8340$1.11M$1.44M0.33%+$333.8K
Nextcure Inc0157,646+157,646$0$923.8K0.21%+$923.8K
An2 Therapeutics Inc715,295715,2950$758.2K$908.4K0.21%+$150.2K
Q32 Bio Inc.(QTTB)277,777277,7770$413.9K$550.0K0.13%+$136.1K
Essa Pharma Inc1,675,0001,675,0000$2.85M$319.9K0.07%-$2.53M
Bolt Biotherapeutics Inc31,30531,3050$180.6K$166.5K0.04%-$14.1K
Ginkgo Bioworks Holdings, Inc.CL A(DNA)2,9282,9280$32.9K$42.7K0.01%+$9.8K
Senseonics Holdings, Inc.(SENS)43,42643,4260$20.7K$18.9K0.00%-$1.7K
Nextcure Inc157,6460-157,646$870.2K$0—-$870.2K
Page 1 of 1